Takaomi Sanda

Sanda Takaomi

Appointment(s)
  • Assistant Professor, Department of Medicine
  • Principal Investigator, Cancer Science Institute of Singapore, National University of Singapore
Academic Qualifications
  • PhD, Nagoya City University Graduate School of Medical Sciences, Japan
  • MD, Nagoya City University Medical School, Japan
Research Interest(s)
  • T Cell Leukaemia
  • Hematopoiesi
  • Transcription Factors
  • Tyrosine Kinases
  • Zebrafish
  • Lymphoma
  • Others
Recent Publications
  • 1. Leong WZ, Tan SH, Ngoc PCT, Amanda S, Yam AWY, Liau W-S, Gong Z, Lawton LN, Tenen DG, Sanda T. 2017 Dec. ARID5B as a critical downstream target of the TAL1 complex that activates the oncogenic transcriptional program and promotes T-cell leukemogenesis. Genes Dev. 31(23-24):2343-2360. doi: 10.1101/gad.302646.117.
  • 2. Wong RWJ, Phuong CTN, Leong WZ, Yam AWY, Zhang T, Asamitsu K, Iida S, Okamoto T, Ueda R, Gray NS et al. 2017 Nov. Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemia. Blood. 130(21):2326-2338. doi: 10.1182/blood-2017-06792184.
  • 3. Sanda T. 2017 Oct. RUNX1 in T-ALL: tumor suppressive or oncogenic?. Blood. 130(15):1686-1688. doi: 10.1182/blood-2017-08-802181.
  • 4. Tan SH, Bertulfo FC, Sanda T. 2017 Sep. Leukemia-initiating cells in T-cell acute lymphoblastic leukemia. Frontiers in Oncology. 7(SEP). doi: 10.3389/fonc.2017.00218.
  • 5. Sanda T, Leong WZ. 2017 Sep. TAL1 as a master oncogenic transcription factor in T-cell acute lymphoblastic leukemia. Experimental Hematology. 53:7-15. doi: 10.1016/j.exphem.2017.06.001.